feed,title,long_url,short_url
BioRxiv,"A nasal vaccine candidate, based on S2 and N proteins from SARS-CoV-2, generates a broad antibody response systemic and at lower respiratory tract",https://www.biorxiv.org/content/10.1101/2025.05.09.653001v1?rss=1,https://da.gd/T4fr4n
